ClinicalTrialsFinder

Clinical Trials in Chelyabinsk, Russia

31 recruiting

Showing 1–20 of 28 trials

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid TumorsHematologic Malignancies

Merck Sharp & Dohme LLC3,500 enrolled779 locationsNCT03486873

Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

Uncontrolled Asthma

AstraZeneca9,000 enrolled47 locationsNCT06521229

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+1 more

Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686

Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

Neurofibromatosis

AstraZeneca200 enrolled13 locationsNCT07088991

Russian Extreme Hypertriglyceridemia Registry

Hypertriglyceridemia

Russian Cardiology Research and Production Center500 enrolled6 locationsNCT07508930

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

AstraZeneca5,000 enrolled37 locationsNCT06472310

Secukinumab Open Label Roll-over Extension Protocol

Autoimmunity, Inflammation

Novartis Pharmaceuticals1,000 enrolled167 locationsNCT04638647

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

AstraZeneca600 enrolled19 locationsNCT07038928

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Endometrial Cancer

AstraZeneca500 enrolled21 locationsNCT07041606

Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

Prostate Cancer

AstraZeneca400 enrolled18 locationsNCT07052578

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)

AstraZeneca2,000 enrolled41 locationsNCT05887011

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Prostate Cancer

AstraZeneca400 enrolled17 locationsNCT07146113

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Biocad24 enrolled14 locationsNCT06700096

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Bayer402 enrolled383 locationsNCT04464226

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis (UC)

Biocad198 enrolled20 locationsNCT07080034

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

Crohn's Disease (CD)

Biocad204 enrolled20 locationsNCT07078994

BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer

Biocad124 enrolled47 locationsNCT07108309

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

Atherosclerotic Cardiovascular Disease

Novartis Pharmaceuticals2,382 enrolled20 locationsNCT06858332

Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

Viral Enteric Infection

POLYSAN Scientific & Technological Pharmaceutical Company300 enrolled8 locationsNCT07066540

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Biocad28 enrolled17 locationsNCT06120582